COMP <GO>
GEVO vs FCX // RSI-14 & 200D SMA MOMENTUM
Gevo Inc. (NASDAQ) VS. Freeport-McMoRan Inc. (NYSE) • 15-METRIC TALLY: GEVO 2
— FCX 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: GEVO
LAST: $1.25 (+3.31%) • MKT CAP: $299.2M
rsi-technicals
43.6
LAST: $62.47 (-5.55%) • MKT CAP: $94.98B
rsi-technicals
43.5
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GEVO VS. FCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GEVO | FCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 26.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.90% | 21.50% | -24.40 | FCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -14.55% | 4.71% | -19.26 | FCX | /fcf-yield <GO> |
| Operating Margin | -12.60% | 25.90% | -38.50 | FCX | /operating-margins <GO> |
| Net Profit Margin | -21.10% | 8.80% | -29.90 | FCX | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 0.10% | +179.90 | GEVO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.91% | -0.91 | FCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 3.08 | -2.88 | FCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | FCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 43.6 | 43.5 | +0.10 | GEVO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 40.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $299.2M | $94.98B | -$94.68B | FCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GEVO REV | FCX REV | GEVO GROSS % | FCX GROSS % | GEVO FCF | FCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $160.6M | $25.19B | — | 26.1% | -$43.5M | $4.48B |
| FY 2024 | $16.9M | $25.17B | — | 29.3% | -$108.5M | $6.03B |
| FY 2023 | $17.2M | $22.70B | — | — | -$53.7M | $4.26B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GEVO // BETA —
FCX // BETA 0.95